Literature DB >> 26781862

Ultraviolet irradiation promotes FOXP3 transcription via p53 in psoriasis.

Dongmei Zhang1, Yang Chen1, Ling Chen2, Riyao Yang3, Li Wang1, Wenying Liu1, Zhifang Zhai1, Zhu Shen1.   

Abstract

The decrease of forkhead box P3-positive (FOXP3 + ) regulatory T cells (Tregs) causes an immune imbalance with effector T cells in psoriasis. Previous studies have demonstrated that in addition to its known effects on keratinocytes and effector T cells, ultraviolet (UV) irradiation alleviates psoriasis via the upregulation of FOXP3 + Tregs. However, the mechanism is unclear. Here, we found that FOXP3 + T cells were increased in psoriatic lesions after UVB irradiation (t' = 3.7006, P < 0.01), as determined by immunohistochemical staining. In addition, the levels of FOXP3 and p53, one of the downstream targets of UV irradiation, showed accordant changes after UV irradiation. Experiments that used a MAPK inhibitor, p53 mutant cell lines, p53 inhibitor and p53 shRNA showed a decrease in FOXP3 levels, suggesting that p53 is required for UV-induced FOXP3 transcription. Next, we demonstrated that there are two binding sites for p53 on FOXP3 by informatics tools, a dual-luciferase reporter assay and chromatin immunoprecipitation (ChIP) assay. One binding site (-1771 to -1583) is located at the promoter region and is adjacent to a previously reported p53-binding region in breast cancer cells. The other (+3845 to +4042) is located within the first intron and has not been previously reported. Our study demonstrated that FOXP3 is regulated, at least in part, by the binding of p53 to several binding sites in the promoter and intron regions following UV irradiation in psoriasis. It will be helpful to further clarify the regulatory mechanism of FOXP3 transcription and to provide new insights into the mechanisms that mediate the effects of UV irradiation in autoimmune skin disorders.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  FOXP3; UV Irradiation; autoimmune disease; p53; psoriasis

Mesh:

Substances:

Year:  2016        PMID: 26781862     DOI: 10.1111/exd.12942

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  9 in total

Review 1.  Oral and Topical Vitamin D, Sunshine, and UVB Phototherapy Safely Control Psoriasis in Patients with Normal Pretreatment Serum 25-Hydroxyvitamin D Concentrations: A Literature Review and Discussion of Health Implications.

Authors:  Patrick J McCullough; William P McCullough; Douglas Lehrer; Jeffrey B Travers; Steven J Repas
Journal:  Nutrients       Date:  2021-04-29       Impact factor: 5.717

Review 2.  A clinical review of phototherapy for psoriasis.

Authors:  Ping Zhang; Mei X Wu
Journal:  Lasers Med Sci       Date:  2017-10-24       Impact factor: 3.161

3.  Ultraviolet B Inhibits IL-17A/TNF-α-Stimulated Activation of Human Dermal Fibroblasts by Decreasing the Expression of IL-17RA and IL-17RC on Fibroblasts.

Authors:  Li Yin; YingYing Hu; JiaLi Xu; Jing Guo; Jie Tu; ZhiQiang Yin
Journal:  Front Immunol       Date:  2017-02-03       Impact factor: 7.561

4.  Functional Polymorphism in the NFE2L2 Gene Associated With Tuberculosis Susceptibility.

Authors:  Guiyi Ji; Miaomiao Zhang; Qianqian Liu; Shouquan Wu; Yu Wang; Guo Chen; Andrew J Sandford; Jian-Qing He
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

5.  p53 Activation Effect in the Balance of T Regulatory and Effector Cell Subsets in Patients With Thyroid Cancer and Autoimmunity.

Authors:  Andrea Arena; Antonio Stigliano; Eugenia Belcastro; Ezio Giorda; Maria Manuela Rosado; Armando Grossi; Maria Rita Assenza; Fabiola Moretti; Alessandra Fierabracci
Journal:  Front Immunol       Date:  2021-08-30       Impact factor: 7.561

6.  High-Throughput RNA Sequencing Reveals the Effect of NB-UVB Phototherapy on Major Inflammatory Molecules of Lesional Psoriasis.

Authors:  Pinyadapat Vacharanukrauh; Jitlada Meephansan; Pattarin Tangtanatakul; Wipasiri Soonthornchai; Jongkonnee Wongpiyabovorn; Onsiri Serirat; Mayumi Komine
Journal:  Psoriasis (Auckl)       Date:  2021-11-26

7.  Mechanism of Huoluo Xiaoling Dan in the Treatment of Psoriasis Based on Network Pharmacology and Molecular Docking.

Authors:  Ke Gong; Wen Guo; Kaiqing Du; Fang Wang; Mengli Li; Jianhui Guo
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-27       Impact factor: 2.629

Review 8.  Current and Future Therapies for Psoriasis with a Focus on Serotonergic Drugs.

Authors:  Ana M Martins; Andreia Ascenso; Helena Margarida Ribeiro; Joana Marto
Journal:  Mol Neurobiol       Date:  2020-02-15       Impact factor: 5.590

Review 9.  Recent advances in phototherapy for psoriasis.

Authors:  Mio Nakamura; Benjamin Farahnik; Tina Bhutani
Journal:  F1000Res       Date:  2016-07-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.